Site Search
410 result(s) found for “ adaptive therapy”
-
Exploring Focal Therapy Options for Prostate Cancer Patients
New effective treatment offers patients treatment option with a lower risk of side effects
-
FDA Approves New Gene Therapy for Synovial Sarcoma
The FDA granted accelerated approval for Tecelra (afamitresgene autoleucel), a groundbreaking gene therapy for metastatic synovial sarcoma.
-
Second-Line Therapy for Large B-Cell Lymphoma
In a recent article published in The New England Journal of Medicine hematologist Dr. Fred Locke, at Moffitt Cancer Center details this...
-
Triplet Therapy Shows Promise in Advanced Lung Cancer
EVOKE-02 study marks an innovative and unconventional approach
-
Dolph Lundgren Receives Targeted Therapy for Kidney Cancer
Drug targets a mutation that is commonly found in lung cancer
-
Expanded TIL Therapy Shows Promise for Sarcoma Patients
Moffitt studying whether AYA population will tolerate the therapy well
-
HIV Therapy Helps Close Cervical Cancer Survival Gap
Study highlights importance of treatment adherence and collaboration between cancer and HIV specialists
-
Moffitt Celebrates Proton Therapy Unit Milestone at Speros
The topping out moment marks a major moment in Pasco campus’s construction
-
New CAR T Therapy Tested for Multiple Myeloma
The cellular targets the B-cell maturation antigen found on malignant plasma cells
-
New Combination Therapy Shows Promise for Leukemia Patients
Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients